Services
Expertises
Resources
Who we are
Biomedical Countermeasures Initiative - Canada
Open

Record updated:

Biomedical Countermeasures Initiative

Accelerating biologics-based medical countermeasure development and evaluation

Get notified when Biomedical Countermeasures Initiative reopens

Location
Canada

Overview

The Biomedical Countermeasures Initiative accelerates the development and evaluation of biologics-based medical countermeasures to strengthen Canada’s response to biological threats, high-consequence pathogens and pandemics. It supports early-to-mid-stage collaborative research through clinical proof of concept, including the development and testing of diagnostics, vaccines and biologics-based therapeutics.
Receipt of requests is now closed
Get notified about updates to this grant.

At a glance

Funding available

Financing goals
  • No objectives are currently available
Eligible Funding
  • Varies by project

Eligible candidates

Eligible Industries
  • All industries
Location
  • Canada
Legal structures
  • All legal structures
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • All groups

Next Steps

1
Determine your project

Availability timeline

2026
No availability periods for this year
Periods: 0

Activities funded

  • Early-to-mid-stage collaborative research through clinical proof of concept.
  • Designing and testing field-deployable diagnostics for biological threats.
  • Developing vaccines and expanding domestic manufacturing capacity.
  • Developing and testing biologics-based therapeutics.
  • Developing biologics-based products for defence readiness and advancing modular tools and technologies for national resilience.

Sources and recorded changes

Record updated

A captured source change or record update does not confirm eligibility. Check the funder’s current rules before applying.

Official page

Biomedical Countermeasures Initiative

Contacts

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Biomedical Countermeasures Initiative Program

What is the Biomedical Countermeasures Initiative?

The Biomedical Countermeasures Initiative accelerates the development and evaluation of biologics-based medical countermeasures to strengthen Canada’s response to biological threats, high-consequence pathogens and pandemics. It supports early-to-mid-stage collaborative research through clinical proof of concept, including the development and testing of diagnostics, vaccines and biologics-based therapeutics.

Who can I contact for more information about the Biomedical Countermeasures Initiative?

You can contact National Research Council Canada (NRC) by email at nrc.BioMCM-CMBiomed.cnrc@nrc-cnrc.gc.ca.

Where is the Biomedical Countermeasures Initiative available?

The Biomedical Countermeasures Initiative program is available across Canada.

Is the Biomedical Countermeasures Initiative a grant, loan, or tax credit?

Biomedical Countermeasures Initiative is a Grant and Funding

Who are the financial supporters of the Biomedical Countermeasures Initiative?

Biomedical Countermeasures Initiative is funded by National Research Council Canada (NRC)